Ocular Therapeutix, Inc (OCUL)

Last Three Months

23-Aug-24 -- 22-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Strong Sell

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

26

0

4

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
27-Aug-24 5:19 PM View:	23-Aug-24 Private Sale ($16.52K)	Nayak Sanjay Chief Strategy Officer		Ocular Therapeutix, Inc - OCUL	(1%) 178.03K to 176.19K	0	0	--	--	Show Txns Hide Txns

27-Aug-24 5:17 PM View:	23-Aug-24 Private Sale ($188.34K)	Dugel Pravin See Remarks Director		Ocular Therapeutix, Inc - OCUL	(3%) 833.35K to 812.47K	0	0	--	--	Show Txns Hide Txns

03-Sep-24 4:08 PM View:	29-Aug-24 Grant 0	Notman Donald See Remarks		Ocular Therapeutix, Inc - OCUL	6% 197.95K to 208.99K	0	0	--	--	Show Txns Hide Txns

04-Oct-24 5:20 PM View:	02-Oct-24 Grant 0	Heier Jeffrey S. Chief Scientific Officer		Ocular Therapeutix, Inc - OCUL	58% 172.01K to 272.01K	0	0	--	--	Show Txns Hide Txns

04-Oct-24 5:21 PM View:	02-Oct-24 Grant 0	Kaiser Peter Chief Development Officer		Ocular Therapeutix, Inc - OCUL	86% 115.98K to 215.98K	0	0	--	--	Show Txns Hide Txns

09-Oct-24 5:32 PM View:	07-Oct-24 Grant 0	Anderman Todd Chief Legal Officer		Ocular Therapeutix, Inc - OCUL	100% 0 to 98.7K	0	0	--	--	Show Txns Hide Txns